موافقات الدواء

Metformin Hydrochloride 500 mg Prolonged Release Tablets is indicated in
• Reduction in the risk or delay of the onset of type 2 diabetes mellitus in adult overweight patients with IGT(Impaired Glucose Tolerance) and/or IFG(Impaired Fasting Glucose) and/or increased HbA1C who are:
-At high risk for developing overt type 2 diabetes mellitus and
-Still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3 to 6 months.
• Treatment of type 2 diabetes mellitus in adults particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. Metformin may be used as monotherapy or in combination.